The AI-Mind Project
Del
10/06/2025
🧠 The AI-Mind Project: Strengthening clinical implementation through key partnerships
📢 Following our strategic reorientation towards real-world impact, we’re excited to spotlight the developments on our path to clinical validation of AI-based tools for dementia risk estimation.
🔬 As detailed in our latest blog post, the addition of three new partners: Universitetet i Oslo (UiO) | University of Oslo, Pre Diagnostics AS and Roche, is playing an important role in this transition. These partners bring complementary expertise in biomarker research, EEG analysis and diagnostics to support AI-Mind advancements.
💡 Notably, Pre Diagnostics is conducting blood analyses using the pTau217 biomarker from over 1,000 study participants.
🏥 With these contributions, AI-Mind is moving steadily from development to deployment, with the ultimate goal to empower healthcare professionals with advanced tools for timely diagnosis.
📖 Read the full article: https://www.ai-mind.eu/blog/from-foundation-to-future-ai-mind-strengthens-clinical-implementation/
🌐 Learn more about our partners: https://www.ai-mind.eu/partners/
🔔 Stay informed on our progress and subscribe for updates: https://www.ai-mind.eu/subscribe/
From Foundation to Future: AI-Mind Strengthens Clinical Implementation The updated consortium structure, implemented in January 2024, reflects AI-Mind’s evolving priorities. Two industrial partners, Pre Diagnostics AS and Roche, have joined the project, bringing essential capabilities in biomarker development, clinical diagnostics, and technology scaling. With this c...
26/05/2025
🧠 The AI-Mind Project joins the COMFORTage - Horizon EU Project Community Forum on Cognitive Decline Prevention 🤖
📢 Ira Hebold Haraldsen, the project coordinator, will present:
"AI-supported pathway of identifying MCI and opening a new window of therapeutic possibilities."
You can still join today at 10:00 CEST
🔗 Register Now: https://ec.europa.eu/eusurvey/runner/6afaf29f-c65c-5a17-db22-6afa3b51b2f1
Starting today with the first webinar from the series, this forum highlights:
✔️ AI & AAL tech for early diagnosis and support
✔️ Cognitive training through smart, engaging tools
✔️ Research and innovation for improving the quality of life for at-risk individuals
Stay tuned for insights from the discussions!
🧠 It’s Brain Awareness Week! 🎉
As we celebrate this global campaign for brain research, the AI-Mind Project continues to spotlight AI-Mind Share on ai-mind.eu - your go-to resource hub for exploring how supports prevention.
In our final video, we introduce the fifth topic on the AI-Mind Share dashboard: 📌 Societal Decision-Making.
🔎 What’s inside?
🔗 A link to an interactive decision model that explores the potential costs and effects of using a dementia risk prediction tool in clinical care.
📊 Tabs providing insights into the model’s structure, the two strategies it compares, and adjustable treatment scenarios.
📈 A results tab displaying key findings and outcomes.
We hope you’ve enjoyed exploring AI-Mind Share and that it becomes a valuable resource for all your dementia-related questions!
Let’s keep the conversation going—how do you see AI shaping the future of dementia prevention? 💬 👇
Dana Foundation
🧠 It’s Brain Awareness Week! 🎉
This global campaign led by The Dana Foundation takes place every March to highlight the progress and benefits of .
In the AI-Mind Project, we are excited to support with the launch of AI-Mind Share – your go-to hub for a wide range of resources on dementia research, mild cognitive impairment (MCI), AI in healthcare, ethical AI use, and data privacy.
🔎 Want to explore?
Visit ai-mind.eu, click on "Outcomes" in the top navigation bar and select "Knowledge hub: AI-Mind Share" to dive into six different topics:
✅ AI-Mind insights on MCI, dementia, risk factors, diagnosis, the use of AI in clinical practice, and innovative tools
✅ Ethical considerations of using AI in healthcare
✅ Managing data privacy and security for AI-Mind tools
✅ Engineering principles behind the AI-Mind solutions
✅ Health Technology Assessment (HTA) for evaluating the potential value and cost-effectiveness of AI-based tools
✅ Complementary information on various knowledge toolboxes developed within the AI-Mind project
🎥 Join us in celebrating and stay tuned for more videos that will demonstrate the features of the new AI-Mind Share.
08/01/2025
🧠Hvem eier egentlig helsedataene til meg og deg? 🩻
Midt i finansielle utfordringer spekuleres det salg av 23andMe, pioneren innen genetisk testing, et salg som kan overføre de genetiske dataene til over 15 millioner kunder, til nye ubestemte eiere.
23andMe har bygget en genetisk database over nesten to tiår, med kunder fra blant annet Norge. Databasen består av detaljerte og sensitive opplysninger om kundenes helse, sykdomsrisiko og slektskap.
Den genetiske koden vår er unik og uforanderlig, noe som gjør misbruk potensielt katastrofalt og livslangt – både på individ- og samfunnsnivå.
Saken har satt søkelyset på en urovekkende
utvikling: Hvem eier egentlig våre helsedata, og hvordan sikrer vi at disse dataene forvaltes etisk og innenfor rammen av demokratiske prinsipper?
Dette skriver prosjektleder for AI-Mind, Ira Hebold Haraldsen om i Dagens Medisin. Les gjerne👇
Når genene våre blir «big business» Når genene våre legges ut på det frie markedet som dagens fangst, til høystbydende, så er det desto viktigere å holde hodet kaldt.
Klikk her for å få din Sponsede Oppføring.
Type
Nettsted
Adresse
Oslo University Hospital
Oslo
Åpningstider
| Mandag | 08:30 - 17:00 |
| Tirsdag | 08:30 - 17:00 |
| Onsdag | 08:30 - 17:00 |
| Torsdag | 08:30 - 17:00 |
| Fredag | 08:30 - 17:00 |
